Results 301 to 310 of about 52,618 (383)

JAK Inhibitors as a Novel Approach to Autoimmune Bullous Diseases: A Review

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Autoimmune bullous diseases (AIBDs) are a group of chronic disorders characterized by blister formation resulting from abnormal immune responses. Janus kinase (JAK) inhibitors have emerged as promising therapeutic agents for AIBDs. This review discusses the use of JAK inhibitors—such as upadacitinib, baricitinib, tofacitinib, and abrocitinib, among ...
Olga Olisova   +9 more
wiley   +1 more source

Intracranial Aneurysm Wall Phenotypes: Clinical, Morphological, and Hemodynamic Influences. [PDF]

open access: yesStroke Vasc Interv Neurol
Karnam Y   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy